We aimed to determine the prevalence of anti-IFN ab in patients with SLE, identify the age and when during the disease course of anti-IFN ab emerge, and assess their association with organ damage.MethodsThis cross-sectional study included 173 SLE patients from the Lund Lupus Cohort. Here, IFNA1 is linked to systemic lupus erythematosus.